Vanda Pharmaceuticals
VNDA
#7861
Rank
โ‚น28.61 B
Marketcap
โ‚น484.22
Share price
3.65%
Change (1 day)
19.62%
Change (1 year)

Revenue for Vanda Pharmaceuticals (VNDA)

Revenue in 2025 (TTM): โ‚น18.34 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น19.05 Billion. In 2024 the company made a revenue of โ‚น17.05 Billion an increase over the revenue in the year 2023 that were of โ‚น16.03 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vanda Pharmaceuticals from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น18.34 B7.58%
2024 โ‚น17.05 B6.33%
2023 โ‚น16.03 B-23.81%
2022 โ‚น21.05 B5.26%
2021 โ‚น19.99 B10.19%
2020 โ‚น18.14 B12.03%
2019 โ‚น16.20 B19.98%
2018 โ‚น13.50 B28.11%
2017 โ‚น10.54 B6.23%
2016 โ‚น9.92 B35.83%
2015 โ‚น7.30 B129.81%
2014 โ‚น3.17 B51.87%
2013 โ‚น2.09 B16.81%
2012 โ‚น1.79 B8.33%
2011 โ‚น1.65 B3.38%
2010 โ‚น1.60 B658.3%
2009 โ‚น0.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚น5.064 T 26,481.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚น5.338 T 27,918.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 T 43,351.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.315 T 22,549.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.640 T 29,505.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.770 T 30,188.96%๐Ÿ‡บ๐Ÿ‡ธ USA